vinorelbine


Also found in: Wikipedia.

vinorelbine

 [vi-nor´el-bēn]
a semisynthetic vinca alkaloid derived from vinblastine; administered intravenously as the tartrate salt as an antineoplastic agent in treatment of non–small cell lung cancer.

vinorelbine

Oncology An anticancer vinca alkaloid. See Vinblastine, Vincristine.

vinorelbine

A vinca alkaloid anticancer drug (see CYTOTOXIC DRUGS) used to treat lung and breast cancer. A brand name is Navelbine.
References in periodicals archive ?
Up to now, microtubule toxin based ADCs from Creative Biolabs have been used in clinical treatment considering the potential side effects, especially toxic moieties, including auristatins, epothilone, maytansinoids, taxoids, tubulysins, and vinorelbine. Researchers at Creative Biolabs specialized in antibody-drug conjugates field have made years of efforts to study a highly efficient conjugation method to avoid toxicity to normal tissues and thus enhance drug concentration in target cancer tissue.
M2 EQUITYBITES-August 5, 2019-Alvogen and Lotus Pharmaceuticals launch Vinorelbine in Europe
M2 PHARMA-August 5, 2019-Alvogen and Lotus Pharmaceuticals launch Vinorelbine in Europe
This approval is based on the results of Study 304,(1) which was a multicenter, open-label, randomized, parallel group Phase III clinical study, to evaluate the efficacy and safety of Halaven and vinorelbine in 530 women with locally recurrent or metastatic breast cancer, previously treated with chemotherapy regimens, including an anthracycline and a taxane.
Patients are randomized to receive either sacituzumab govitecan or physician's choice of eribulin, capecitabine, gemcitabine or vinorelbine. The primary endpoint will be progression-free survival with overall survival serving as secondary endpoint.
The global, randomised, open-label, multi-centre phase III trial of 302 patients, assessed the efficacy and safety of Lynparza tablets (300mg twice daily) compared to the physician's choice of chemotherapy (capecitabine, eribulin or vinorelbine).
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non small-cell lung cancer: A Southwest oncology group trial.
At the time of writing this manuscript, the patient's medication was changed to vinorelbine.
Several other chemotherapeutic agents, including cyclophosphamide, doxorubicin, cisplatin, paclitaxel, and vinorelbine, have been associated with C.
One hundred and twelve cases of gemcitabine were treated with platinum group, 11 cases were combined with platinum and vinorelbine, six cases of paclitaxel combined with platinum group, and 23 cases of pemetrexed combined with platinum therapy.
For example, cisplatin and pemetrexed might be proposed for first-line treatment (standard treatment), followed by an experimental maintenance study (study NCT01358084), with another standard treatment for the second line (gemcitabine) and third line (vinorelbine).